Univest
Univest
  • Markets

Where Will Take Solutions Share Price Be in the Next 3 Years?

  • August 3, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments

Take Solutions share price Rs 22.83. 52W high Rs 50.1, low Rs 8.83. Market cap Rs 341 Cr. 2030 scenario range Rs 18.1 to Rs 62.3.

The Take Solutions share price outlook for the next 3 years is a question on many investors’ minds as the stock trades at Rs 22.83, within a 52 week range of Rs 8.83 to Rs 50.1. This article lays out a scenario based Take Solutions share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Take Solutions Company Overview
  • Where Does Take Solutions Share Price Stand Today?
  • Take Solutions Share Price Outlook: Key Growth Drivers for the Next 3 Years
    • Client Additions and Deal Pipeline
    • Digitisation Tailwinds in Life Sciences IT and Regulatory Tech
    • Company Specific Catalysts
    • Macro Environment and Liquidity
  • Take Solutions Share Price Outlook 2027, 2028 and 2030: Scenario Analysis
  • Bull Case vs Bear Case for Take Solutions Share Price
    • The Bull Case
    • The Bear Case
  • Key Risks That Could Change the Take Solutions Share Price Outlook
  • Is Take Solutions Worth Watching for the Long Term?
  • Conclusion
  • FAQs on Take Solutions Share Price Outlook
    • What is the Take Solutions share price outlook for the next 3 years?
    • What is the future of Take Solutions share price?
    • What is the Take Solutions share price outlook for 2027?
    • What is the Take Solutions share price projection for 2030?
    • What is the current share price of Take Solutions?
    • Is Take Solutions a good stock for the long term?
    • What are the key risks to the Take Solutions share price outlook?

Take Solutions Company Overview

Take Solutions is a Chennai based provider of life sciences data, regulatory technology and supply chain solutions for pharmaceutical and healthcare clients. Understanding the business model is the first step in framing any credible Take Solutions share price outlook, because the durability of earnings ultimately decides where the stock trades.

Company Take Solutions
NSE Ticker TAKE
Sector Life Sciences IT and Regulatory Tech
CMP Rs 22.83
52 Week High Rs 50.1
52 Week Low Rs 8.83
Market Cap Rs 341 Cr

Where Does Take Solutions Share Price Stand Today?

The stock currently trades about 54 percent below its 52 week high of Rs 50.1, which means the market has already priced in some caution. For anyone building a Take Solutions share price outlook, this starting point matters, because entry valuations have a large bearing on 3 year returns.

At the current price, Take Solutions commands a market capitalisation of Rs 341 Cr. These figures anchor the Take Solutions share price outlook scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Take Solutions Share Price Outlook: Key Growth Drivers for the Next 3 Years

A handful of forces are likely to shape the Take Solutions share price outlook between now and 2030, and together they explain most of the dispersion in this Take Solutions share price outlook. Each is discussed below with its likely direction of impact.

Client Additions and Deal Pipeline

Stock prices ultimately follow earnings. The stock has moved sharply within its 52 week range of Rs 8.83 to Rs 50.10, reflecting a business still working through a turnaround. The pace at which this plays out over FY27 to FY30 will be one of the biggest determinants of the Take Solutions share price outlook actually materialising.

Digitisation Tailwinds in Life Sciences IT and Regulatory Tech

Take Solutions operates in the life sciences it and regulatory tech space, where sector-wide demand and pricing cycles influence how investors value the stock. Structural tailwinds in this segment, if sustained, support the more optimistic end of the Take Solutions share price outlook.

Company Specific Catalysts

Growing global demand for pharma regulatory compliance and clinical data management software is the structural tailwind for this niche. If this plays out on schedule, the Take Solutions share price outlook for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay for Take Solutions. A benign macro backdrop supports the optimistic end of this Take Solutions share price outlook, while global risk aversion would do the opposite.

Take Solutions Share Price Outlook 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Take Solutions share price outlook using compounded growth assumptions applied to the current market price of Rs 22.83. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year Bear Case Base Case Bull Case Assumption
2027 Rs 21.1 Rs 26.3 Rs 31.9 -5% to 25% CAGR on CMP
2028 Rs 20.1 Rs 29 Rs 39.9 -5% to 25% CAGR on CMP
2030 Rs 18.1 Rs 35.1 Rs 62.3 -5% to 25% CAGR on CMP

In the base case scenario of this Take Solutions share price outlook, the 2030 level works out to roughly Rs 35.1, implying steady compounding from today’s levels. The bull case of Rs 62.3 plays out if growing global demand for pharma regulatory compliance and clinical data management software is the structural tailwind for this niche, which would let both earnings and the valuation multiple re-rate higher, while the bear case of Rs 18.1 captures a scenario where growth stalls. That is an outcome band of about -21 percent to 173 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Projection

Bull Case vs Bear Case for Take Solutions Share Price

The Bull Case

The optimistic Take Solutions share price outlook assumes growing global demand for pharma regulatory compliance and clinical data management software is the structural tailwind for this niche. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 62.3 by 2030.

The Bear Case

The cautious view centres on the fact that extreme price volatility over the past year signals that earnings visibility and investor confidence remain works in progress. If these pressures dominate, the Take Solutions share price outlook would skew toward the lower band and the stock could stagnate near Rs 18.1 even by 2030, underperforming broader indices.

Key Risks That Could Change the Take Solutions Share Price Outlook

  • Execution risk: Delays in scaling operations, branch or capacity expansion, or new business lines could push the earnings trajectory below the base case.
  • Valuation risk: At the current earnings multiple, any disappointment on profit growth can trigger sharp multiple compression before fundamentals stabilise.
  • Sector risk: Extreme price volatility over the past year signals that earnings visibility and investor confidence remain works in progress.
  • Macro risk: A global or domestic slowdown, adverse FII flows or unexpected rate moves would compress equity valuations broadly, including for this stock.
  • Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little advance warning.

Is Take Solutions Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Take Solutions share price outlook lands in 2030 or what any single Take Solutions share price outlook says today, but whether the business can compound capital through cycles. The stock has moved sharply within its 52 week range of Rs 8.83 to Rs 50.10, reflecting a business still working through a turnaround. That gives Take Solutions a credible story to track, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Take Solutions share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Take Solutions share price live.

Conclusion

The Take Solutions share price outlook for the next 3 years spans Rs 18.1 to Rs 62.3 by 2030 under the scenarios discussed, with a base case near Rs 35.1. Any credible Take Solutions share price outlook must be updated as facts change, and the path will be decided by earnings delivery, sector conditions and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Take Solutions Share Price Outlook

What is the Take Solutions share price outlook for the next 3 years?

Ans. The Take Solutions share price outlook for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 18.1 in the bear case to Rs 62.3 in the bull case, with a base case near Rs 35.1, depending on earnings delivery and market conditions.

What is the future of Take Solutions share price?

Ans. The future of Take Solutions share price depends largely on how the company executes against its growth drivers over FY27 to FY30, alongside sector conditions and the broader market environment. Historically, businesses that deliver consistent earnings tend to see steadier price outcomes over such horizons.

What is the Take Solutions share price outlook for 2027?

Ans. For 2027, the scenario range works out to roughly Rs 21.1 to Rs 31.9, with a base case around Rs 26.3. This is illustrative and not a guaranteed outcome, and actual prices will depend on quarterly results and market sentiment.

What is the Take Solutions share price projection for 2030?

Ans. The Take Solutions share price projection for 2030 spans Rs 18.1 to Rs 62.3 across the bear and bull scenarios discussed in this article, with the base case near Rs 35.1. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What is the current share price of Take Solutions?

Ans. Take Solutions currently trades at around Rs 22.83 on the NSE, within a 52 week range of Rs 8.83 to Rs 50.1. Prices change continuously during market hours, so check live quotes before acting.

Is Take Solutions a good stock for the long term?

Ans. Take Solutions has a growth story worth watching: the stock has moved sharply within its 52 week range of Rs 8.83 to Rs 50.10, reflecting a business still working through a turnaround. At the same time it carries risks, since extreme price volatility over the past year signals that earnings visibility and investor confidence remain works in progress. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What are the key risks to the Take Solutions share price outlook?

Ans. The main risks are execution delays, valuation compression if earnings disappoint, sector-specific pressures, macro shocks such as adverse FII flows or rate moves, and regulatory or policy changes. Any of these can push the stock below the base case scenario discussed in this article.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply